Not applicableStudy completedNCT01308229What this trial is testingSafety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation StentWho this might be right forCoronary Disease MINVASYS 102
Not applicableStudy completedNCT02013349What this trial is testingDESolve Post-Approval StudyWho this might be right forCoronary Artery Disease Elixir Medical Corporation 102
Testing effectiveness (Phase 2)Study completedNCT01294748What this trial is testingClinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery DiseaseWho this might be right forCoronary Artery Disease Micell Technologies 184
Not applicableStudy completedNCT00856856What this trial is testingABSORB Clinical Investigation, Cohort BWho this might be right forCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis Abbott Medical Devices 101
Testing effectiveness (Phase 2)Study completedNCT00248079What this trial is testingThe Medtronic RESOLUTE Clinical TrialWho this might be right forCoronary Artery Disease Medtronic Vascular 139
Large-scale testing (Phase 3)Study completedNCT00180479What this trial is testingSPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)Who this might be right forStentsCoronary Artery DiseaseTotal Coronary Occlusion+5 more Abbott Medical Devices 1,002
Not applicableNot Yet RecruitingNCT07098195What this trial is testingTo Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent SystemWho this might be right forCoronary Artery DiseaseCoronary Artery StenosisPercutaneous Coronary Intervention+1 more Poly Medicure Limited 2,000
Not applicableStudy completedNCT01638507What this trial is testingAn Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent SystemWho this might be right forCoronary Artery Disease Medtronic Vascular 230
Not applicableStudy completedNCT00726453What this trial is testingThe Medtronic RESOLUTE US Clinical TrialWho this might be right forCoronary Artery Disease Medtronic Vascular 1,516
Not applicableStudy completedNCT01121744What this trial is testingSupralimus-Core™ Pharmacokinetic (PK) StudyWho this might be right forCoronary Artery Disease Sahajanand Medical Technologies Limited 20
Not applicableStudy completedNCT02173379What this trial is testingAbsorb IV Randomized Controlled TrialWho this might be right forCoronary Artery DiseaseCoronary Artery StenosisCoronary Disease+1 more Abbott Medical Devices 2,604
Not applicableStudy completedNCT04282148What this trial is testingAbbott Next Generation Drug Eluting Stent 48mm StudyWho this might be right forCoronary Artery Disease Abbott Medical Devices 107
Not applicableUnknownNCT00474084What this trial is testingHydroxyapatite Active Pro Healing Clinical Trial ProgramWho this might be right forCoronary Artery Disease BioSync Scientific Pvt. Ltd. 70
Large-scale testing (Phase 3)Study completedNCT00307047What this trial is testingSPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent SystemWho this might be right forCoronary Artery Disease Abbott Medical Devices 3,687
Not applicableStudy completedNCT02086045What this trial is testingElixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx TrialWho this might be right forCoronary Artery Disease Elixir Medical Corporation 126
Not applicableStudy completedNCT01583608What this trial is testingABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery DiseaseWho this might be right forCardiovascular DiseasesCoronary Artery DiseaseMyocardial Ischemia+7 more Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. 183
Not applicableUnknownNCT02817802What this trial is testingBIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IVWho this might be right forCoronary Artery Disease Biotronik AG 2,066
Not applicableStudy completedNCT02455804What this trial is testingNIRTRAKS Post-Market Study (NIRTRAKS)Who this might be right forde Novo Stenotic Lesions in Native Coronary Arteries Medinol Ltd. 65
Testing effectiveness (Phase 2)Study completedNCT00233766What this trial is testingEvaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)Who this might be right forCoronary Artery Disease Cordis US Corp. 60
Not applicableStudy completedNCT01258972What this trial is testingProspective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native CoronariesWho this might be right forCoronary Atherosclerosis of Native Coronary ArteryBifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary Artery Tryton Medical, Inc. 133